Collegium Pharmaceutical Inc
NASDAQ:COLL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
US |
|
R
|
Resonance Specialties Ltd
BSE:524218
|
IN |
|
H
|
H S India Ltd
BSE:532145
|
IN |
|
I
|
Ingram Micro Holding Corp
NYSE:INGM
|
US |
|
Atari SA
PAR:ALATA
|
FR |
|
S
|
Shanghai Rendu Biotechnology Co Ltd
SSE:688193
|
CN |
|
Y
|
Yuasa Trading Co Ltd
TSE:8074
|
JP |
|
Novatti Group Ltd
ASX:NOV
|
AU |
|
I
|
Investors House Oyj
OMXH:INVEST
|
FI |
Revenue Breakdown
Breakdown by Geography
Collegium Pharmaceutical Inc
Breakdown by Segments
Collegium Pharmaceutical Inc
|
Total Revenue:
780.6m
USD
|
|
Represents Information Pertaining To The Sing...:
631.4m
USD
|
|
Represents Information Pertaining To Belbuca:
211.3m
USD
|
|
Represents The Information Pertaining To Xtampza:
191.3m
USD
|
|
Represents Information Pertaining To Nucynta Ir:
100.7m
USD
|
|
Represents Information Pertaining To Nucynta Er:
75.8m
USD
|
|
Represents Information Pertaining To Jornay Pm:
37.2m
USD
|
|
Represents Information Pertaining To Symproic:
15.1m
USD
|